These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17468231)

  • 1. Epidermolysis bullosa: a genetic disease of altered cell adhesion and wound healing, and the possible clinical utility of topically applied thymosin beta4.
    Fine JD
    Ann N Y Acad Sci; 2007 Sep; 1112():396-406. PubMed ID: 17468231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries.
    Yang WS; Kang S; Sung J; Kleinman HK
    Eur J Dermatol; 2019 Oct; 29(5):459-467. PubMed ID: 31649007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural findings in epidermolysis bullosa.
    Smith LT
    Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disorders of the cutaneous basement membrane zone--the paradigm of epidermolysis bullosa.
    Bruckner-Tuderman L; Has C
    Matrix Biol; 2014 Jan; 33():29-34. PubMed ID: 23917088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited epidermolysis bullosa.
    Fine JD
    Orphanet J Rare Dis; 2010 May; 5():12. PubMed ID: 20507631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the basic and clinical applications of thymosin β4.
    Goldstein AL; Kleinman HK
    Expert Opin Biol Ther; 2015; 15 Suppl 1():S139-45. PubMed ID: 26096726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birch Bark Extract: A Review in Epidermolysis Bullosa.
    Heo YA
    Drugs; 2023 Sep; 83(14):1309-1314. PubMed ID: 37658982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermolysis bullosa in animals: a review.
    Medeiros GX; Riet-Correa F
    Vet Dermatol; 2015 Feb; 26(1):3-13, e1-2. PubMed ID: 25354580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inherited epidermolysis bullosa: new diagnostic criteria and classification.
    Intong LR; Murrell DF
    Clin Dermatol; 2012; 30(1):70-7. PubMed ID: 22137229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleogel-S10 Phase 3 study "EASE" for epidermolysis bullosa: study design and rationale.
    Kern JS; Schwieger-Briel A; Löwe S; Sumeray M; Davis C; Martinez AE
    Trials; 2019 Jun; 20(1):350. PubMed ID: 31186047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Keratin gel in the management of Epidermolysis bullosa.
    Denyer J; Marsh C; Kirsner RS
    J Wound Care; 2015 Oct; 24(10):446-50. PubMed ID: 26488735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial.
    Fine JD; Manes B; Frangoul H
    J Am Acad Dermatol; 2015 Jul; 73(1):56-61. PubMed ID: 25956659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4.
    Dunn SP; Heidemann DG; Chow CY; Crockford D; Turjman N; Angel J; Allan CB; Sosne G
    Ann N Y Acad Sci; 2010 Apr; 1194():199-206. PubMed ID: 20536469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa.
    Chelliah MP; Zinn Z; Khuu P; Teng JMC
    Pediatr Dermatol; 2018 Jul; 35(4):e224-e227. PubMed ID: 29786144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research advances on thymosin β4 in promoting wound healing].
    Gao YX; Wang LF; Ba SJ; Cao JL; Li F; Li B; Zhou B
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2022 Apr; 38(4):378-384. PubMed ID: 35462518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of laminin 5 in rat skin wounds regulated by recombinant thymosin beta4].
    Li Y; Wang G; Yu H; Yang X; Xu S; Nie L; Che Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Nov; 22(11):1306-10. PubMed ID: 19068595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study.
    Kern JS; Sprecher E; Fernandez MF; Schauer F; Bodemer C; Cunningham T; Löwe S; Davis C; Sumeray M; Bruckner AL; Murrell DF;
    Br J Dermatol; 2023 Jan; 188(1):12-21. PubMed ID: 36689495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in epidermolysis bullosa: genetic classification and clinical implications.
    Uitto J; Richard G
    Am J Med Genet C Semin Med Genet; 2004 Nov; 131C(1):61-74. PubMed ID: 15468152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymosin β4 Promotes Dermal Healing.
    Kleinman HK; Sosne G
    Vitam Horm; 2016; 102():251-75. PubMed ID: 27450738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
    Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
    Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.